-transparent.png){kind=logo}
Preoperative chemotherapy for esophageal cancer was performed and the toxic effects, post-operative complications, histological effects and survival time were evaluated. Toxic effects and post-operative complications were rare. The histological effect was evaluated according to the Guidelines for Clinical and pathologic studies on carcinoma of the esophagus by the Japanese Society for Esophageal Disease. A histological effect of more than Grade II was seen from 25 to 42.1%. A significant difference was seen in the Kaplan-Meier survival curves between the response group and the no response group (p < 0.05). If we perform preoperative chemotherapy for esophageal cancer only to responsive cases determined by chemosensitivity tests, the prognosis of advanced esophageal cancer may be improved.
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
January 1999,
Surgery today,
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
January 2003,
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
June 2018,
Esophagus : official journal of the Japan Esophageal Society,
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
June 1995,
Annals of surgery,
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
January 1986,
Zhonghua zhong liu za zhi [Chinese journal of oncology],
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
December 1999,
Journal of cancer research and clinical oncology,
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
January 2016,
Pathology international,
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
March 2009,
The Israel Medical Association journal : IMAJ,
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
February 2024,
General thoracic and cardiovascular surgery,
M Ohara, and
K Ishihara, and
T Abe, and
S Yamazaki, and
T Miura, and
Y Tanabe, and
M Kusano, and
T Okayasu, and
M Hosokawa, and
M Fujita
May 2008,
Oncology reports,
